scholarly article | Q13442814 |
P50 | author | Kevin M Weiss | Q59686812 |
P2093 | author name string | Douglas K Owens | |
Sandeep Vijan | |||
Amir Qaseem | |||
Vincenza Snow | |||
J Thomas Cross | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | type 2 diabetes | Q3025883 |
P304 | page(s) | 417-22 | |
P577 | publication date | 2007-09-18 | |
P1433 | published in | Annals of Internal Medicine | Q564416 |
P1476 | title | Glycemic control and type 2 diabetes mellitus: the optimal hemoglobin A1c targets. A guidance statement from the American College of Physicians | |
P478 | volume | 147 |
Q36168515 | A growing disparity in diabetes-related mortality U.S. trends, 1989-2005. |
Q46030861 | Advanced glycation end products in diabetic patients with optimized glycaemic control and their effects on endothelial reactivity: possible implications in venous graft failure. |
Q47249275 | Agreement between the 'point of care' tests for microalbuminuria and HbA1c performed in mexican family medicine units and the results of standard laboratory tests. |
Q34820877 | An evaluation of recruitment methods utilized for a clinical trial with periodontal and diabetes enrollment criteria: the Diabetes and Periodontal Therapy Trial |
Q50128815 | Associations Between Health Care Factors and Self-Reported Health Status Among Individuals with Diabetes: Results from a Community Assessment |
Q96770874 | Citizenship and health insurance status predict glycemic management: NHANES data 2007-2016 |
Q37139441 | Combined measurement of fasting plasma glucose and A1C is effective for the prediction of type 2 diabetes: the Kansai Healthcare Study |
Q39942990 | Compromised periodontal status in an urban Sri Lankan population with type 2 diabetes |
Q53172684 | Critical appraisal of quality of clinical practice guidelines for treatment of psoriasis vulgaris, 2006-2009. |
Q50856514 | Differential subtypes of diabetic older adults diagnosed with Alzheimer's disease. |
Q37050949 | Do clinical standards for diabetes care address excess risk for hypoglycemia in vulnerable patients? A systematic review |
Q40764658 | Drugs that reverse disease transcriptomic signatures are more effective in a mouse model of dyslipidemia |
Q51740478 | Effect of Omega-3 Fatty Acids Dietary Supplementation on Ocular Surface and Tear Film in Diabetic Patients with Dry Eye. |
Q34012168 | Effects of glucose and blood pressure control on diabetic kidney disease in old patients with type 2 diabetes |
Q46112566 | Ethnic variation in the correlation between random serum glucose concentration and glycated haemoglobin |
Q37374891 | Evaluation of quality of life and depression levels in individuals with Type 2 diabetes |
Q33932057 | Evolving trends in insulin delivery in pursuit of improvements in diabetes management |
Q58805293 | Factors that Correlate with Poor Glycemic Control in Type 2 Diabetes Mellitus Patients with Complications |
Q43711367 | Glycaemic separation and risk factor control in the Veterans Affairs Diabetes Trial: an interim report. |
Q34281482 | Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses |
Q30426632 | Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus |
Q84794122 | Guidelines: we’ll always need them, we sometimes dislike them, and we have to make them better |
Q37326229 | Hemoglobin A1c: past, present and future |
Q34153401 | Hidden complexities in assessment of glycemic outcomes: are quality rankings aligned with treatment? |
Q39324361 | Impact of a quality improvement intervention on provider adherence to recommended standards of care for adults with type 2 diabetes mellitus |
Q48875298 | Impact of dementia on caring for patients' diabetes |
Q37427254 | Implementing treatment guidelines for type 2 diabetes in primary care |
Q35577429 | Improved sleep quality in older adults with insomnia reduces biomarkers of disease risk: pilot results from a randomized controlled comparative efficacy trial |
Q40192480 | Inadequate control of diabetes and metabolic indices among diabetic patients: A population based study from the Kerman Coronary Artery Disease Risk Study (KERCADRS). |
Q58701346 | Incidence rates of dysvascular lower extremity amputation changes in Northern Netherlands: A comparison of three cohorts of 1991-1992, 2003-2004 and 2012-2013 |
Q33848334 | Insulin analogs and glycosylated hemoglobin target of less than 7% in type 2 diabetes: a systematic review of randomized trials. |
Q37959159 | Intensive glycemic control and cardiovascular disease: are there patients who may benefit? |
Q39936865 | KDIGO clinical practice guideline for the care of kidney transplant recipients |
Q46783597 | Laboratory markers of diabetes mellitus in the elderly |
Q26799608 | Mechanisms of hypoglycemia unawareness and implications in diabetic patients |
Q36842005 | Mitigating case mix factors by choice of glycemic control performance measure threshold |
Q36243180 | National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations. |
Q50749642 | Patient adherence or patient self-management in transplantation: an ethical analysis. |
Q37227893 | Pharmacoepidemiology of insulin initiation in diabetes care |
Q43237620 | Pharmacokinetic and pharmacodynamic properties of taspoglutide, a once-weekly, human GLP-1 analogue, after single-dose administration in patients with Type 2 diabetes |
Q55397745 | Pioglitazone and cardiovascular risk in T2DM patients: is it good for all? |
Q36477793 | Public health implications of recommendations to individualize glycemic targets in adults with diabetes |
Q38185302 | Quality indicators and performance measures in diabetes care |
Q36926147 | Severe Hypoglycemia Requiring Medical Intervention in a Large Cohort of Adults With Diabetes Receiving Care in U.S. Integrated Health Care Delivery Systems: 2005-2011. |
Q38605102 | Shared Decision-Making in Diabetes Care |
Q47115045 | Sodium-glucose Cotransporter-2 Inhibitors: Moving Beyond the Glycemic Treatment Goal |
Q36925939 | The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis |
Q36686257 | The importance of hypoglycemia in diabetic patients |
Q30840235 | The physician's experience of changing clinical practice: a struggle to unlearn |
Q83901347 | The relationship between cognitive impairment and diabetes self-management in a population-based community sample of older adults with Type 2 diabetes |
Q33441898 | The systematic guideline review: method, rationale, and test on chronic heart failure |
Q46459922 | To what extent should we lower HbA1c in diabetic subjects? |
Q45924271 | Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis. |
Q37153041 | Type 2 diabetes mellitus is associated with multiple cardiometabolic risk factors |
Search more.